OGC
IDXX icon

Oak Grove Capital’s Idexx Laboratories IDXX Stock Holding History

Oak Grove Capital’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-3,300
Closed -$862K – 67
2019
Q4 		$862K Buy
3,300
+1,510
+84% +$398K 0.34% 46
2019
Q3 		$487K Buy
1,790
+900
+101% +$250K 0.21% 54
2019
Q2 		$245K Buy
+890
New +$219K 0.13% 63

Other funds holding IDXX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Oak Grove Capital's IDXX Position: Q1 2020 in Review

Oak Grove Capital sold out of Idexx Laboratories (IDXX) in Q1 2020, closing a stake of 3,300 shares — an estimated $862K sold.

Oak Grove Capital first reported a position in IDXX in Q2 2019 and held it in 3 quarters. The position peaked at $862K in Q4 2019. 748 funds tracked by Wall St. Rank hold IDXX as of Q1 2020.

  • Oak Grove Capital reported no remaining Idexx Laboratories position as of Q1 2020 after selling out during the quarter.
  • Oak Grove Capital sold 3,300 Idexx Laboratories shares in Q1 2020, an estimated $862K.
  • Oak Grove Capital first reported a position in Idexx Laboratories in Q2 2019 and held it in 3 quarters.
  • Oak Grove Capital's Idexx Laboratories position peaked at $862K in Q4 2019.
  • 748 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2020.

Based on Oak Grove Capital's 13F filing for Q1 2020, filed 11 May 2020.